Kudo K - Search Results

1

Aza-derivatives of resveratrol are potent macrophage migration inhibitory factor inhibitors.

Fujita Y, Islam R, Sakai K, Kaneda H, Kudo K, Tamura D, Aomatsu K, Nagai T, Kimura H, Matsumoto K, de Velasco MA, Arao T, Okawara T, Nishio K. Fujita Y, et al. Among authors: kudo k. Invest New Drugs. 2012 Oct;30(5):1878-86. doi: 10.1007/s10637-011-9749-7. Epub 2011 Sep 13. Invest New Drugs. 2012. PMID: 21912888

2

SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesion.

Tanaka K, Arao T, Maegawa M, Matsumoto K, Kaneda H, Kudo K, Fujita Y, Yokote H, Yanagihara K, Yamada Y, Okamoto I, Nakagawa K, Nishio K. Tanaka K, et al. Among authors: kudo k. Int J Cancer. 2009 Mar 1;124(5):1072-80. doi: 10.1002/ijc.24065. Int J Cancer. 2009. PMID: 19065654

3

Epidermal growth factor receptor lacking C-terminal autophosphorylation sites retains signal transduction and high sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor.

Maegawa M, Arao T, Yokote H, Matsumoto K, Kudo K, Tanaka K, Kaneda H, Fujita Y, Ito F, Nishio K. Maegawa M, et al. Among authors: kudo k. Cancer Sci. 2009 Mar;100(3):552-7. doi: 10.1111/j.1349-7006.2008.01071.x. Epub 2009 Jan 14. Cancer Sci. 2009. PMID: 19154417 Free PMC article.

4

mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells.

Matsumoto K, Arao T, Tanaka K, Kaneda H, Kudo K, Fujita Y, Tamura D, Aomatsu K, Tamura T, Yamada Y, Saijo N, Nishio K. Matsumoto K, et al. Among authors: kudo k. Cancer Res. 2009 Sep 15;69(18):7160-4. doi: 10.1158/0008-5472.CAN-09-1289. Epub 2009 Sep 8. Cancer Res. 2009. PMID: 19738050

5

FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth.

Kaneda H, Arao T, Tanaka K, Tamura D, Aomatsu K, Kudo K, Sakai K, De Velasco MA, Matsumoto K, Fujita Y, Yamada Y, Tsurutani J, Okamoto I, Nakagawa K, Nishio K. Kaneda H, et al. Among authors: kudo k. Cancer Res. 2010 Mar 1;70(5):2053-63. doi: 10.1158/0008-5472.CAN-09-2161. Epub 2010 Feb 9. Cancer Res. 2010. PMID: 20145154

6

Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transition.

Tamura D, Arao T, Tanaka K, Kaneda H, Matsumoto K, Kudo K, Aomatsu K, Fujita Y, Watanabe T, Saijo N, Kotani Y, Nishimura Y, Nishio K. Tamura D, et al. Among authors: kudo k. Cancer Sci. 2010 Jun;101(6):1403-8. doi: 10.1111/j.1349-7006.2010.01544.x. Epub 2010 Mar 15. Cancer Sci. 2010. PMID: 20367638 Free PMC article.

7

Antitumor activity of BIBF 1120, a triple angiokinase inhibitor, and use of VEGFR2+pTyr+ peripheral blood leukocytes as a pharmacodynamic biomarker in vivo.

Kudo K, Arao T, Tanaka K, Nagai T, Furuta K, Sakai K, Kaneda H, Matsumoto K, Tamura D, Aomatsu K, De Velasco MA, Fujita Y, Saijo N, Kudo M, Nishio K. Kudo K, et al. Among authors: kudo m. Clin Cancer Res. 2011 Mar 15;17(6):1373-81. doi: 10.1158/1078-0432.CCR-09-2755. Epub 2010 Dec 3. Clin Cancer Res. 2011. PMID: 21131553

8

TGF-β induces sustained upregulation of SNAI1 and SNAI2 through Smad and non-Smad pathways in a human corneal epithelial cell line.

Aomatsu K, Arao T, Sugioka K, Matsumoto K, Tamura D, Kudo K, Kaneda H, Tanaka K, Fujita Y, Shimomura Y, Nishio K. Aomatsu K, et al. Among authors: kudo k. Invest Ophthalmol Vis Sci. 2011 Apr 14;52(5):2437-43. doi: 10.1167/iovs.10-5635. Invest Ophthalmol Vis Sci. 2011. PMID: 21169525

9

Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma.

Nagai T, Arao T, Furuta K, Sakai K, Kudo K, Kaneda H, Tamura D, Aomatsu K, Kimura H, Fujita Y, Matsumoto K, Saijo N, Kudo M, Nishio K. Nagai T, et al. Among authors: kudo m, kudo k. Mol Cancer Ther. 2011 Jan;10(1):169-77. doi: 10.1158/1535-7163.MCT-10-0544. Mol Cancer Ther. 2011. PMID: 21220499

10

Acquired drug resistance to vascular endothelial growth factor receptor 2 tyrosine kinase inhibitor in human vascular endothelial cells.

Arao T, Matsumoto K, Furuta K, Kudo K, Kaneda H, Nagai T, Sakai K, Fujita Y, Tamura D, Aomatsu K, Koizumi F, Nishio K. Arao T, et al. Among authors: kudo k. Anticancer Res. 2011 Sep;31(9):2787-96. Anticancer Res. 2011. PMID: 21868521

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,759 results

Search Page

Filters